Cargando…
Phase I study of neoadjuvant S‐1 plus cisplatin with concurrent radiation for biliary tract cancer (Tokyo Study Group for Biliary Cancer: TOSBIC02)
AIM: Neoadjuvant chemoradiotherapy may improve survival in patients with advanced cholangiocarcinoma. This Phase I study aimed to determine the recommended dose of neoadjuvant chemoradiotherapy and decide whether to move to a Phase II study. METHODS: Patients diagnosed with resectable stage II–IVa c...
Autores principales: | Abe, Yuta, Itano, Osamu, Takemura, Yusuke, Minagawa, Takuya, Ojima, Hidenori, Shinoda, Masahiro, Kitago, Minoru, Obara, Hideaki, Shigematsu, Naoyuki, Kitagawa, Yuko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472356/ https://www.ncbi.nlm.nih.gov/pubmed/37663959 http://dx.doi.org/10.1002/ags3.12682 |
Ejemplares similares
-
A prospective feasibility study of one-year administration of adjuvant S-1 therapy for resected biliary tract cancer in a multi-institutional trial (Tokyo Study Group for Biliary Cancer: TOSBIC01)
por: Itano, Osamu, et al.
Publicado: (2020) -
Gamma‐synuclein is a novel prognostic marker that promotes tumor cell migration in biliary tract carcinoma
por: Takemura, Yusuke, et al.
Publicado: (2021) -
Surgical and Oncological Outcomes of Salvage Hepatectomy for Locally Recurrent Hepatocellular Carcinoma after Locoregional Therapy: A Single-Institution Experience
por: Minagawa, Takuya, et al.
Publicado: (2023) -
Techniques of biliary drainage for acute cholangitis: Tokyo Guidelines
por: Tsuyuguchi, Toshio, et al.
Publicado: (2007) -
Techniques of biliary drainage for acute cholecystitis: Tokyo Guidelines
por: Tsuyuguchi, Toshio, et al.
Publicado: (2007)